Lin28 promotes transformation and is associated with advanced human malignancies

Nature Genetics

Volumn 41, Issue 7, 2009, Pages 843-848

  Viswanathan, Srinivas R ^a   Powers, John T ^a   Einhorn, William ^a   Hoshida, Yujin ^b,c,s   Ng, Tony L ^d,e   Toffanin, Sara ^f,g   O'Sullivan, Maureen ^h,i   Lu, Jun ^b,c,s   Phillips, Letha A ^j   Lockhart, Victoria L ^k   Shah, Samar P ^a   Tanwar, Pradeep S ^l   Mermel, Craig H ^c,s   Beroukhim, Rameen ^c,s   Azam, Mohammad ^a   Teixeira, Jose ^l   Meyerson, Matthew ^c,s   Hughes, Timothy P ^m   Llovet, Josep M ^f,n,o   Radich, Jerald ^k   Mullighan, Charles G ^j   Golub, Todd R ^b,c,p,s   Sorensen, Poul H ^d,e   Daley, George Q ^a,b,p,q,r   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h OUR LADY S CHILDREN S HOSPITAL   (Ireland)

ⁱ TRINITY COLLEGE DUBLIN   (Ireland)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^k Fred Hutchinson Cancer Research Center   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

ⁿ HOSPITAL CLÍNIC   (Spain)

^o INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^p HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r Manton Center for Orphan Disease Research   (United States)

^s DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN LIN28; PROTEIN LIN28B; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; MICRORNAS; NEOPLASMS; RNA-BINDING PROTEINS;

EID: 67649881121     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.392     Document Type: Article

References (58)

1. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
2. Thomson, J.M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202-2207 (2006).
3. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677 (2007).
4. Kumar, M.S. et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA 105, 3903-3908 (2008).
5. Heo, I. et al. Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol. Cell 32, 276-284 (2008).
6. Newman, M.A., Thomson, J.M. & Hammond, S.M. Lin-28 interaction with the let-7 precursor loop mediates regulated microRNA processing. RNA 14, 1539-1549 (2008).
7. Rybak, A. et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol. 10, 987-993 (2008).
8. Viswanathan, S.R., Daley, G.Q. & Gregory, R.I. Selective blockade of microRNA processing by Lin28. Science 320, 97-100 (2008).
9. Inamura, K. et al. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Lung Cancer 58, 392-396 (2007).
10. Takamizawa, J. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756 (2004).
11. Gramantieri, L. et al. Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099 (2007).
12. Schultz, J., Lorenz, P., Gross, G., Ibrahim, S. & Kunz, M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 18, 549-557 (2008).
13. Shell, S. et al. Let-7 expression defines two differentiation stages of cancer. Proc. Natl. Acad. Sci. USA 104, 11400-11405 (2007).
14. Esquela-Kerscher, A. et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7, 759-764 (2008).
15. Lee, Y.S. & Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030 (2007).
16. Mayr, C., Hemann, M.T. & Bartel, D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579 (2007).
17. Zhang, L. et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA 105, 7004-7009 (2008).
18. Nagayama, K. et al. Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosom. Cancer 46, 1000-1010 (2007).
19. Yamada, H. et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosom. Cancer 47, 810-818 (2008).
20. Lu, L., Katsaros, D., Rigault de la Longrais, I., Sochirca, O. & Yu, H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67, 10117-10122 (2007).
21. Keath, E.J., Caimi, P.G. & Cole, M.D. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39, 339-348 (1984).
22. Dangi-Garimella, S. et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 28, 347-358 (2009).
23. Piskounova, E. et al. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J. Biol. Chem. 283, 21310-21314 (2008).
24. Engelman, A. & Rosenberg, N. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation. Mol. Cell. Biol. 10, 4365-4369 (1990).
25. Meyer, B., Krisponeit, D., Junghanss, C., Escobar, H.M. & Bullerdiek, J. Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count. Leuk. Lymphoma 48, 2008-2013 (2007).
26. Bruecher-Encke, B., Griffin, J.D., Neel, B.G. & Lorenz, U. Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation. Leukemia 15, 1424-1432 (2001).
27. Chiang, D.Y. et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 68, 6779-6788 (2008).
28. Hoshida, Y. et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 359, 1995-2004 (2008).
29. Korshunov, A., Sycheva, R., Golanov, A. & Pronin, I. Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas. Am. J. Clin. Pathol. 127, 585-590 (2007).
30. Dai, Z. et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum. Mol. Genet. 12, 791-801 (2003).
31. Summersgill, B. et al. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br. J. Cancer 77, 305-313 (1998).
32. Chang, T.C. et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. USA 106, 3384-3389 (2009).
33. Anglesio, M.S. et al. Differential expression of a novel ankyrin containing E3 ubiquitinprotein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Hum. Mol. Genet. 13, 2061-2074 (2004).
34. Bruce, C.K., Howard, P., Nowak, N.J. & Hoban, P.R. Molecular analysis of region t(5;6)(q21;q21) in Wilms tumor. Cancer Genet. Cytogenet. 141, 106-113 (2003).
35. Fernandez, C.V., Lestou, V.S., Wildish, J., Lee, C.L.Y. & Sorensen, P.H.B. Detection of a novel t(6;15)(q21;q21) in a pediatric Wilms tumor. Cancer Genet. Cytogenet. 129, 165-167 (2001).
36. Hoban, P.R. et al. Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour. J. Med. Genet. 34, 343-345 (1997).
37. Zhang, L. et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat. Med. 13, 1060-1069 (2007).
38. Richards, M., Tan, S.P., Tan, J.H., Chan, W.K. & Bongso, A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 51-64 (2004).
39. Eckfeldt, C.E. et al. Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol. 3, e254 (2005).
40. Yang, D.H. & Moss, E.G. Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse. Gene Expr. Patterns 3, 719-726 (2003).
41. Bell, D.A. Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18, S19-S32 (2005).
42. Lee, J.S. et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 12, 410-416 (2006).
43. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
44. Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260 (2003).
45. Gidekel, S., Pizov, G., Bergman, Y. & Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361-370 (2003).
46. Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121, 465-477 (2005).
47. Ben Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (2008).
48. Hartwell, K.A. et al. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc. Natl. Acad. Sci. USA 103, 18969-18974 (2006).
49. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
50. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
51. Llovet, J.M., Burroughs, A. & Bruix, J. Hepatocellular carcinoma. Lancet 362, 1907-1917 (2003).
52. Azam, M., Seeliger, M.A., Gray, N.S., Kuriyan, J. & Daley, G.Q. Activation of tyrosine kinases by mutation of the gatekeeper threonine. Nat. Struct. Mol. Biol. 15, 1109-1118 (2008).
53. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
54. Park, I.H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
55. Lee, J.C. et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 3, e485 (2006).
56. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
57. Hupe, P., Stransky, N., Thiery, J.P., Radvanyi, F. & Barillot, E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20, 3413-3422 (2004).
58. Mullighan, C.G. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453, 110-114 (2008).